PTC Therapeutics
PTCT
#3357
Rank
NZ$6.41 B
Marketcap
NZ$80.90
Share price
-0.16%
Change (1 day)
60.52%
Change (1 year)

PTC Therapeutics (PTCT) - Total liabilities

Total liabilities on the balance sheet as of March 2025 : NZ$4.68 Billion

According to PTC Therapeutics 's latest financial reports the company's total liabilities are NZ$4.68 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

PTC Therapeutics - Total liabilities on balance sheet (from 2012 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31NZ$4.97 B15.8%
2023-12-31NZ$4.29 B32.75%
2022-12-31NZ$3.23 B14.03%
2021-12-31NZ$2.83 B18.51%
2020-12-31NZ$2.39 B56.52%
2019-12-31NZ$1.52 B33.42%
2018-12-31NZ$1.14 B245.92%
2017-12-31NZ$0.33 B53.19%
2016-12-31NZ$0.21 B6.24%
2015-12-31NZ$0.20 B358.81%
2014-12-31NZ$44.35 M137.28%
2013-12-31NZ$18.69 M-52.34%
2012-12-31NZ$39.22 M-89.17%
2011-12-31NZ$0.36 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Vertex Pharmaceuticals
VRTX
NZ$10.52 B 124.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
NZ$3.82 B-18.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
NZ$0.18 B-96.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNA
NZ$0.21 B-95.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
NZ$0.43 B-90.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$101.37 B 2,064.23%๐Ÿ‡จ๐Ÿ‡ญ Switzerland